Updates

Updates & Press

Latest news, announcements, and press releases from Neurotype.

Latest Updates

Recent milestones, partnerships, and recognitions.

US Patent No. 12,343,157 - EEG & Machine Learning Cue-Reactive Brain States Addiction Interventions

US Patent Issued

July 1, 2025

" NeuromarkR™ platform has been issued US Patent No. 12,343,157 for EEG & Machine Learning Cue-Reactive Brain States Addiction Interventions.... "

Novel medical devices to address the opioid crisis

Nature Medicine

National Institute on Drug Abuse

" National Institute on Drug Abuse (NIDA) supports the development of new medical devices to treat Substance Use Disorders and the opioid crisis.... "

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to encourage more widespread innovation and development of new treatments for opioid use disorder

US Food And Drug Administration

Office of the Commissioner

" US Food and Drug Administration prioritizes development of tools to help treat opioid cravings.... "

Mayo Clinic

Office of Entrepreneurship

" Neurotype Inc. participates in 2023 Mayo Clinic Walleye Tank innovation competition.... "

Babson College

KMH Health Entrepreneurship

" CEO of Neurotype Inc. selected for the 2023 Babson College SUD Sprint cohort.... "

Scott Burwell, PhD, presents at the NIH/NIDA/FDA/CDRH workshop on "Diagnostic and Monitoring Medical Devices for Opioid Use Disorder."

NIH / FDA

Bethesda, MD

" Scott Burwell, PhD, CEO of Neurotype, presents at the NIH/NIDA/FDA/CDRH workshop on "Diagnostic and Monitoring Medical Devices for Opioid Use Disorder... "

Contact Us

For press inquiries and additional information.

Get in Touch